Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
Q4 net sales of $84.1 million and $310.0 million for full year 2024; continued growth expected in 2025Executing on ...
PharmiWeb23h
Prostate cancer: HCPs discuss emerging therapies, clinical trials, imaging and AI diagnostics on social media
A new study into the online conversations of healthcare professionals discussing prostate cancer has revealed a strong focus on emerging therapies, the latest clinical trials, AI-driven diagnostics ...